Clinical Trials Browser

Phase 2/3 × Neoplasm Metastasis × Dexmedetomidine × Clear all

NCT03936205 2019-05-14

Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer

Phase 2/3 Completed

Neoplasm Metastasis, Pain, Intractable